Lukas Scheibler

Lukas Scheibler

Company: Apellis

Job title: Chief Innovation Officer

Seminars:

The Role of Complement in Dry-AMD 10:00 am

Review the role of complement, specifically C3, in the pathology of dry-AMD Advance the targeted C3 therapy for the treatment of geographic Atrophy An update from the phase 3 clinical studies of pegcetacoplan in dry-AMDRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.